Institution
OHSU Knight Cancer Institute
Also known as: Knight Cancer Institute · Oregon Health & Science University Knight Cancer Institute · Oregon Health and Science University Knight Cancer Institute
- 77running trials
- 35closed trials
- 6,381publications (OpenAlex)
Running trials
Not yet recruiting
Recruiting
Not yet recruiting
Not yet recruiting
Recruiting
177Lu-DOTATATE for the Treatment of Stage IV or Recurrent Breast Cancer
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
GET FIT Together: Testing a Socially Enhanced Exercise Program in Older Men With Prostate Cancer
Not yet recruiting
Recruiting
Recruiting
Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors
Recruiting
OMO-103 for the Treatment of Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Vaccine Responses in Patient With Multiple Myeloma and Non-Hodgkin Lymphoma After CAR-T Treatment
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Evaluation of the Change in PSMA Expression in Prostate Cancer in Response to Hormonal Therapy
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Internet-Based Lifestyle Intervention to Eradicate Obese Frailty in Prostate Cancer Survivors, iLIVE
Recruiting
Active, not recruiting
ONC-392 Plus Lutetium Lu 177 Vipivotide Tetraxetan in Patients With mCRPC
Active, not recruiting
Recruiting
Recruiting
Outcomes in Pediatric and Young Adult B-Cell Malignancies After Commercially Available Immunotherapy
Recruiting
Colonoscopy vs Stool Testing for Older Adults With Colon Polyps
Active, not recruiting
Recruiting
Recruiting
Impact of Dietary Fiber Supplementation on Colonic Microbiome
Active, not recruiting
Improving Decision-Making Encounters in Lung Cancer Using a Low-Literacy Conversation Tool
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT
Active, not recruiting
Showing 50 of 77.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer9 recruiting
- Acute myeloid leukaemia7 recruiting
- Pancreatic cancer6 recruiting
- Colorectal cancer5 recruiting
- Diffuse large B-cell lymphoma5 recruiting
- Prostate cancer5 recruiting
- Childhood cancers4 recruiting
- Mantle cell lymphoma4 recruiting
- Myelodysplastic syndromes4 recruiting
- Chronic lymphocytic leukaemia3 recruiting
- Head and neck cancer3 recruiting
- Liver and biliary tract cancer3 recruiting
- Bladder cancer2 recruiting
- Follicular lymphoma2 recruiting
- Gastric and oesophageal cancer2 recruiting
- Melanoma2 recruiting
- Metastatic breast cancer2 recruiting
- Atrial fibrillation1 recruiting
- Burkitt lymphoma1 recruiting
- Glioblastoma1 recruiting
- Hodgkin lymphoma1 recruiting
- Immune thrombocytopenia (ITP)1 recruiting
- Kidney cancer1 recruiting
- Mesothelioma1 recruiting
- Multiple myeloma1 recruiting
- Myeloproliferative neoplasms1 recruiting
- Obesity1 recruiting
- Ovarian cancer1 recruiting
Closed trials
Terminated
Completed
BEST-RPP Pilot: Screening for Esophageal Cancer in Rural Oregon Without an Endoscopy
Withdrawn
Completed
Withdrawn
Completed
Electronic Quitline Referral With Enhanced Academic Detailing for the Promotion of Smoking Cessation
Completed
Enhancing Skin Cancer Early Detection and Treatment in Primary Care
Terminated
Terminated
Recruiting
BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia
Completed
Completed
Humidified Forest Oils for Immune System Recovery in Stage I-III Breast or Prostate Cancer
Completed
Integrative Health Interventions in Symptom Management of Pediatric Patients
Terminated
Terminated
Completed
Completed
Terminated
Completed
Decision Aid for the Improvement of Decision-Making in Patients With Non-small Cell Lung Cancer
Completed
Completed
Completed
Glucarpidase After High-Dose Methotrexate in Patients With Osteosarcoma
Completed
Terminated
Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer
Completed
Completed
A Phase 1 Study of FOR46 in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Completed
Terminated
Completed
Phase 1-2 Study of Low Dose ASTX727 (ASTX727 LD) in Lower Risk MDS
Terminated
Ferumoxytol MRI in Assessing Response to Pembrolizumab in Patients With Glioblastoma
Completed
Completed
Completed
Terminated
Completed
Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer
Registry name variants (20)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
OHSU Knight Cancer Institute
Portland, Oregon 97239
86 trials
Knight Cancer Institute at Oregon Health and Science University
Portland, Oregon 97239-3098
5 trials
Oregon Health & Science University, Knight Cancer Institute
Portland, Oregon 97210
5 trials
Oregon Health and Science University Knight Cancer Institute
Portland, Oregon 97239
4 trials
OHSU Knight Cancer Institute, Beaverton
Beaverton, Oregon 97006
2 trials
OHSU Knight Cancer Institute, East Portland
Portland, Oregon 97216
2 trials
OHSU Knight Cancer Institute, Gresham
Gresham, Oregon 97030
2 trials
OHSU Knight Cancer Institute, Tualatin
Tualatin, Oregon 97062
2 trials
Oregon Health & Sciences University - Knight Cancer Institute
Portland, Oregon 97239
2 trials
Oregon Health & Science University - OHSU Knight Cancer Institute
Portland, Oregon 97201
2 trials
Contact: Astellas Pharma Global Development, Inc.
NCT05429632Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT
Contact: Arpita Gandhi, MD
Knight Cancer Institute
Portland, Oregon 97239
1 trial
OHSU Knight Cancer Institute, Northwest
Portland, Oregon 97210
1 trial
OHSU Knight Cancer Institute, Northwest Portland
Portland, Oregon 97210
1 trial
OHSU Knight Cancer Institute (Site 1075)
Portland, Oregon 97210
1 trial
OHSU Knight Cancer Institute - South Waterfront (Site 0110)
Portland, Oregon 97239
1 trial
Contact: Study Coordinator
Oregon Health and Science University, Knight Cancer Institute - Marquam Hill
Portland, Oregon 97239
1 trial
NCT06251310SW-682 in Advanced Solid Tumors
Contact: Shivaani Kummar (principal investigator)
Oregon Health and Science University Knight Cancer Institute - Northwest Portland
Portland, Oregon 97210
1 trial
Oregon Health and Science University (OHSU) Knight Cancer Institute
Portland, Oregon 97210
1 trial
Oregon Health & Science University, Knight Cancer Institute-
Portland, Oregon 97239
1 trial
Oregon Health & Science University - Knight Cancer Institute Site Number: 8400006
Portland, Oregon 97239
1 trial
Conditions
Diseases this institution publishes on or runs trials for.
- Acute myeloid leukaemia32 works · 12 trials
- Ovarian cancer29 works · 3 trials
- Myelodysplastic syndromes11 works · 7 trials
- Chronic myeloid leukaemia6 works · 1 trial
Institution data: ROR 002shna07 (CC0-1.0)Updated 15 Nov 2026